Stem cells, PRP technology boost global orthobiologics market: 5 observations

Written by Megan Wood | May 16, 2017 | Print  |

The introduction of new products leveraging platelet rich plasma and stem cell technology is driving the global orthobiologics market's growth.

Here are five observations:

 

1. The growing adoption of viscosupplementation products, bone marrow concentrate and specific growth factors are also key market drivers.

 

2. Within the market, the autograft segment dominates due to their compatibility and reduced side effects.

 

3. Platelet rich plasma is gaining popularity in the sports medicine market.

 

4. North America and Europe lead the space, with the Asia-Pacific region and Latin America set for significant growth.

 

5. Key market players include Stryker, Arthrex, Isto Biologics, Anika Therapeutics, RTI Surgical, DePuy Synthes, Lattice Biologics, SeaSpine and Citagenix.

 

More articles on devices:
DePuy Synthes receives up to $260M US Department of Defense contract: 5 key notes
Mazor, Xtant Medical, InVivo Therapeutics & more: 18 device company key notes
Histogenics receives innovation award

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months